Advertisement

The Role of Phenylephrine in Perioperative Medicine

  • C. Ertmer
  • A. Morelli
  • M. Westphal

Abstract

Phenylephrine is a synthetic, direct sympathomimetic agent that is mainly used to induce locoregional vasoconstriction. For this purpose, phenylephrine is contained in several decongestant nasal sprays [1] and mydriatics [2] in doses usually not exerting significant systemic cardiovascular effects. In 1976, oral phenylephrine was approved for non-prescription use as a decongestant by the Food and Drug Administration (FDA) [3]. In addition, local phenylephrine injection may be considered to treat regional hyperemia, e.g., in patients with priapism [4]. Intravenous phenylephrine represents an effective vasopressor in a variety of clinical indications, particularly including Cesarean section and cardiovascular surgery. This chapter summarizes the pharmacology of intravenous phenylephrine and clinical studies investigating its use in the perioperative setting and provides recommendations for perioperative use.

Keywords

Septic Shock Carotid Endarterectomy Septic Shock Patient Arterial Hypotension Coronary Perfusion Pressure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Myers MG, Iazzetta JJ (1982) Intranasally administered phenylephrine and blood pressure. Can Med Assoc J 127: 365–368PubMedGoogle Scholar
  2. 2.
    Tanner V, Casswell AG (1996) A comparative study of the efficacy of 2.5 % phenylephrine and 10 % phenylephrine in pre-operative mydriasis for routine cataract surgery. Eye 10: 95–98PubMedGoogle Scholar
  3. 3.
    Department of Health, Education, and Welfare, Food and Drug Administration (1976) Establishment of a monograph for OTC cold, cough, allergy, bronchodilator, and antiasthmatic products. Fed Regist 41: 38399–38400Google Scholar
  4. 4.
    Azocar Hidalgo G, Van Cauwelaert R, Castillo Cadiz O, Aguirre Aguirre C, Wohler Campos C (1994) [Treatment of priapism with phenylephrine]. Arch Esp Urol 47: 785–787Google Scholar
  5. 5.
    Hengstmann JH, Goronzy J (1982) Pharmacokinetics of 3H-phenylephrine in man. Eur J Clin Pharmacol 21: 335–341CrossRefPubMedGoogle Scholar
  6. 6.
    Plumb DC (2002) Veterinary Drug Handbook, 4th edn. PharmaVet Publishing, White Bear LakeGoogle Scholar
  7. 7.
    La Rovere MT, Pinna GD, Raczak G (2008) Baroreflex sensitivity: measurement and clinical implications. Ann Noninvasive Electrocardiol 13: 191–207CrossRefPubMedGoogle Scholar
  8. 8.
    Hinder F, Stubbe HD, Van Aken H, et al (2003) Early multiple organ failure after recurrent endotoxemia in the presence of vasoconstrictor-masked hypovolemia. Crit Care Med 31: 903–909CrossRefPubMedGoogle Scholar
  9. 9.
    Imran M, Khan FH, Khan MA (2007) Attenuation of hypotension using phenylephrine during induction of anaesthesia with propofol. J Pak Med Assoc 57: 543–547PubMedGoogle Scholar
  10. 10.
    Goertz AW, Schmidt M, Seefelder C, Lindner KH, Georgieff M (1993) The effect of phenylephrine bolus administration on left ventricular function during isoflurane-induced hypotension. Anesth Analg 77: 227–231PubMedGoogle Scholar
  11. 11.
    Ikeda T, Ozaki M, Sessler DI, Kazama T, Ikeda K, Sato S (1999) Intraoperative phenylephrine infusion decreases the magnitude of redistribution hypothermia. Anesth Analg 89: 462–465CrossRefPubMedGoogle Scholar
  12. 12.
    Kwak YL, Lee CS, Park YH, Hong YW (2002) The effect of phenylephrine and norepinephrine in patients with chronic pulmonary hypertension. Anaesthesia 57: 9–14CrossRefPubMedGoogle Scholar
  13. 13.
    Ishiyama T, Oguchi T, Iijima T, Matsukawa T, Kashimoto S, Kumazawa T (2003) Ephedrine, but not phenylephrine, increases bispectral index values during combined general and epidural anesthesia. Anesth Analg 97: 780–784CrossRefPubMedGoogle Scholar
  14. 14.
    Takizawa D, Takizawa E, Miyoshi S, et al (2006) The effect of ephedrine and phenylephrine on BIS values during propofol anaesthesia. Eur J Anaesthesiol 23: 654–657CrossRefPubMedGoogle Scholar
  15. 15.
    Sharrock NE, Go G, Mineo R (1991) Effect of i.v. low-dose adrenaline and phenylephrine infusions on plasma concentrations of bupivacaine after lumbar extradural anaesthesia in elderly patients. Br J Anaesth 67: 694–698CrossRefPubMedGoogle Scholar
  16. 16.
    Sharrock NE, Go G, Mineo R, Harpel PC (1992) The hemodynamic and fibrinolytic response to low dose epinephrine and phenylephrine infusions during total hip replacement under epidural anesthesia. Thromb Haemost 68: 436–441PubMedGoogle Scholar
  17. 17.
    Sharrock NE, Mineo R, Go G (1993) The effect of cardiac output on intraoperative blood loss during total hip arthroplasty. Reg Anesth 18: 24–29PubMedGoogle Scholar
  18. 18.
    Brooker RF, Butterworth JF, Kitzman DW, Berman JM, Kashtan HI, McKinley AC (1997) Treatment of hypotension after hyperbaric tetracaine spinal anesthesia. A randomized, double-blind, cross-over comparison of phenylephrine and epinephrine. Anesthesiology 86: 797–805CrossRefPubMedGoogle Scholar
  19. 19.
    Baraka A, Haroun S, Baroody MA, et al (1991) The hemodynamic effects of intravenous norepinephrine versus epinephrine and phenylephrine in patients with ischemic heart disease. Middle East J Anesthesiol 11: 53–62PubMedGoogle Scholar
  20. 20.
    Kugiyama K, Ohgushi M, Motoyama T, et al (1999) Enhancement of constrictor response of spastic coronary arteries to acetylcholine but not to phenylephrine in patients with coronary spastic angina. J Cardiovasc Pharmacol 33: 414–419CrossRefPubMedGoogle Scholar
  21. 21.
    Skubas N, Barner HB, Apostolidou I, Lappas DG (2005) Phenylephrine to increase blood flow in the radial artery used as a coronary bypass conduit. J Thorac Cardiovasc Surg 130: 687–692CrossRefPubMedGoogle Scholar
  22. 22.
    Goertz AW, Lindner KH, Seefelder C, Schirmer U, Beyer M, Georgieff M (1993) Effect of phenylephrine bolus administration on global left ventricular function in patients with coronary artery disease and patients with valvular aortic stenosis. Anesthesiology 78: 834–841CrossRefPubMedGoogle Scholar
  23. 23.
    Goertz AW, Lindner KH, Schutz W, Schirmer U, Beyer M, Georgieff M (1994) Influence of phenylephrine bolus administration on left ventricular filling dynamics in patients with coronary artery disease and patients with valvular aortic stenosis. Anesthesiology 81: 49–58CrossRefPubMedGoogle Scholar
  24. 24.
    Tanaka K, Kitahata H, Kawahito S, Nozaki J, Tomiyama Y, Oshita S (2003) Phenylephrine increases pulmonary blood flow in children with tetralogy of Fallot. Can J Anaesth 50: 926–929CrossRefPubMedGoogle Scholar
  25. 25.
    Howell SJ (2007) Carotid endarterectomy. Br J Anaesth 99: 119–131CrossRefPubMedGoogle Scholar
  26. 26.
    Ghogawala Z, Westerveld M, Amin-Hanjani S (2008) Cognitive outcomes after carotid revascularization: the role of cerebral emboli and hypoperfusion. Neurosurgery 62: 385–395CrossRefPubMedGoogle Scholar
  27. 27.
    Mutch WA, White IW, Donen N, et al (1995) Haemodynamic instability and myocardial ischaemia during carotid endarterectomy: a comparison of propofol and isoflurane. Can J Anaesth 42: 577–587CrossRefPubMedGoogle Scholar
  28. 28.
    Borum SE, Bittenbinder TM, Buckley CJ (2000) Transesophageal atrial pacing reduces phenylephrine needed for blood pressure support during carotid endarterectomy. J Cardiothorac Vasc Anesth 14: 277–280CrossRefPubMedGoogle Scholar
  29. 29.
    Smith JS, Roizen MF, Cahalan MK, et al (1988) Does anesthetic technique make a difference? Augmentation of systolic blood pressure during carotid endarterectomy: effects of phenylephrine versus light anesthesia and of isoflurane versus halothane on the incidence of myocardial ischemia. Anesthesiology 69: 846–853CrossRefPubMedGoogle Scholar
  30. 30.
    Turkoz A, Togal T, Gokdeniz R, Toprak HI, Ersoy O (2002) Effectiveness of intravenous ephedrine infusion during spinal anaesthesia for caesarean section based on maternal hypotension, neonatal acid-base status and lactate levels. Anaesth Intensive Care 30: 316–320PubMedGoogle Scholar
  31. 31.
    Aniset L, Konrad C, Schley M (2006) [Ephedrine as alternative to Akrinor in regional obstetric anesthesia]. Anaesthesist 55: 784–790CrossRefPubMedGoogle Scholar
  32. 32.
    James FM 3rd, Greiss FC, Jr., Kemp RA (1970) An evaluation of vasopressor therapy for maternal hypotension during spinal anesthesia. Anesthesiology 33: 25–34CrossRefPubMedGoogle Scholar
  33. 33.
    Deiml R, Hess W, Bahlmann E (2000) [Primary cesarean section. Use of phenylephrine during anesthesia in a patient with hypertrophic obstructive cardiomyopathy]. Anaesthesist 49: 527–531CrossRefPubMedGoogle Scholar
  34. 34.
    Moran DH, Perillo M, LaPorta RF, Bader AM, Datta S (1991) Phenylephrine in the prevention of hypotension following spinal anesthesia for cesarean delivery. J Clin Anesth 3: 301–305CrossRefPubMedGoogle Scholar
  35. 35.
    LaPorta RF, Arthur GR, Datta S (1995) Phenylephrine in treating maternal hypotension due to spinal anaesthesia for caesarean delivery: effects on neonatal catecholamine concentrations, acid base status and Apgar scores. Acta Anaesthesiol Scand 39: 901–905CrossRefPubMedGoogle Scholar
  36. 36.
    Pierce ET, Carr DB, Datta S (1994) Effects of ephedrine and phenylephrine on maternal and fetal atrial natriuretic peptide levels during elective cesarean section. Acta Anaesthesiol Scand 38: 48–51CrossRefPubMedGoogle Scholar
  37. 37.
    Hall PA, Bennett A, Wilkes MP, Lewis M (1994) Spinal anaesthesia for caesarean section: comparison of infusions of phenylephrine and ephedrine. Br J Anaesth 73: 471–474CrossRefPubMedGoogle Scholar
  38. 38.
    Thomas DG, Robson SC, Redfern N, Hughes D, Boys RJ (1996) Randomized trial of bolus phenylephrine or ephedrine for maintenance of arterial pressure during spinal anaesthesia for Caesarean section. Br J Anaesth 76: 61–65PubMedGoogle Scholar
  39. 39.
    Cooper DW, Carpenter M, Mowbray P, Desira WR, Ryall DM, Kokri MS (2002) Fetal and maternal effects of phenylephrine and ephedrine during spinal anesthesia for cesarean delivery. Anesthesiology 97: 1582–1590CrossRefPubMedGoogle Scholar
  40. 40.
    Ngan Kee WD, Lee A, Khaw KS, Ng FF, Karmakar MK, Gin T (2008) A randomized doubleblinded comparison of phenylephrine and ephedrine infusion combinations to maintain blood pressure during spinal anesthesia for cesarean delivery: the effects on fetal acid-base status and hemodynamic control. Anesth Analg 107: 1295–1302CrossRefPubMedGoogle Scholar
  41. 41.
    Loughrey JP, Yao N, Datta S, Segal S, Pian-Smith M, Tsen LC (2005) Hemodynamic effects of spinal anesthesia and simultaneous intravenous bolus of combined phenylephrine and ephedrine versus ephedrine for cesarean delivery. Int J Obstet Anesth 14: 43–47CrossRefPubMedGoogle Scholar
  42. 42.
    Ayorinde BT, Buczkowski P, Brown J, Shah J, Buggy DJ (2001) Evaluation of pre-emptive intramuscular phenylephrine and ephedrine for reduction of spinal anaesthesia-induced hypotension during Caesarean section. Br J Anaesth 86: 372–376CrossRefPubMedGoogle Scholar
  43. 43.
    Ngan Kee WD, Khaw KS, Ng FF (2004) Comparison of phenylephrine infusion regimens for maintaining maternal blood pressure during spinal anaesthesia for Caesarean section. Br J Anaesth 92: 469–474CrossRefGoogle Scholar
  44. 44.
    Ngan Kee WD, Khaw KS, Ng FF, Lee BB (2004) Prophylactic phenylephrine infusion for preventing hypotension during spinal anesthesia for cesarean delivery. Anesth Analg 98: 815–821CrossRefGoogle Scholar
  45. 45.
    Ngan Kee WD, Khaw KS, Ng FF (2005) Prevention of hypotension during spinal anesthesia for cesarean delivery: an effective technique using combination phenylephrine infusion and crystalloid cohydration. Anesthesiology 103: 744–750CrossRefGoogle Scholar
  46. 46.
    Ngan Kee WD, Tam YH, Khaw KS, Ng FF, Critchley LA, Karmakar MK (2007) Closed-loop feedback computer-controlled infusion of phenylephrine for maintaining blood pressure during spinal anaesthesia for caesarean section: a preliminary descriptive study. Anaesthesia 62: 1251–1256CrossRefGoogle Scholar
  47. 47.
    Erler I, Gogarten W (2007) [Prevention and treatment of hypotension during Caesarean delivery]. Anasthesiol Intensivmed Notfallmed Schmerzther 42: 208–213CrossRefPubMedGoogle Scholar
  48. 48.
    Dunser MW, Mayr AJ, Ulmer H, et al (2001) The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg 93: 7–13CrossRefPubMedGoogle Scholar
  49. 49.
    Nygren A, Thoren A, Ricksten SE (2006) Vasopressors and intestinal mucosal perfusion after cardiac surgery: Norepinephrine vs. phenylephrine. Crit Care Med 34: 722–729CrossRefPubMedGoogle Scholar
  50. 50.
    O’Dwyer C, Woodson LC, Conroy BP, et al (1997) Regional perfusion abnormalities with phenylephrine during normothermic bypass. Ann Thorac Surg 63: 728–735CrossRefPubMedGoogle Scholar
  51. 51.
    Dellinger RP, Levy MM, Carlet JM, et al (2008) Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34: 17–60CrossRefPubMedGoogle Scholar
  52. 52.
    Reinelt H, Radermacher P, Kiefer P, et al (1999) Impact of exogenous beta-adrenergic receptor stimulation on hepatosplanchnic oxygen kinetics and metabolic activity in septic shock. Crit Care Med 27: 325–331CrossRefPubMedGoogle Scholar
  53. 53.
    Beale RJ, Hollenberg SM, Vincent JL, Parrillo JE (2004) Vasopressor and inotropic support in septic shock: an evidence-based review. Crit Care Med 32 (Suppl 11):S455–465CrossRefGoogle Scholar
  54. 54.
    Gregory JS, Bonfiglio MF, Dasta JF, Reilley TE, Townsend MC, Flancbaum L (1991) Experience with phenylephrine as a component of the pharmacologic support of septic shock. Crit Care Med 19: 1395–1400CrossRefPubMedGoogle Scholar
  55. 55.
    Flancbaum L, Dick M, Dasta J, Sinha R, Choban P (1997) A dose-response study of phenylephrine in critically ill, septic surgical patients. Eur J Clin Pharmacol 51: 461–465CrossRefPubMedGoogle Scholar
  56. 56.
    Hofmann BB, Lefkowitz RJ (1990) Catecholamines and sympathomimetic drugs. In: Gilman AG, Rail TW, Nies AS, Taylor P (eds) Goodman and Gilman’s The Pharmacological Basis of Therapeutics. Pergamon, New York, pp 187–220Google Scholar
  57. 57.
    Rivers E, Nguyen B, Havstad S, et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: 1368–1377CrossRefPubMedGoogle Scholar
  58. 58.
    Rivers E, Coba V, Whitmill M (2008) Early goal directed therapy in severe sepsis and septic shock: A Contemporary review of the literature. Curr Opin Anesthesiol 21: 128–140CrossRefGoogle Scholar
  59. 59.
    Parrillo JE (2008) Septic shock—vasopressin, norepinephrine, and urgency. N Engl J Med 358: 954–956CrossRefPubMedGoogle Scholar
  60. 60.
    Sander O, Welters ID, Foex P, Sear JW (2005) Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with a high risk of cardiac complications. Crit Care Med 33: 81–88CrossRefPubMedGoogle Scholar
  61. 61.
    Morelli A, Lange M, Ertmer C, et al (2008) Short-term effects of phenylephrine on systemic and regional hemodynamics in patients with septic shock: A crossover pilot study. Shock 29: 446–451CrossRefPubMedGoogle Scholar
  62. 62.
    Rich S, Gubin S, Hart K (1990) The effects of phenylephrine on right ventricular performance in patients with pulmonary hypertension. Chest 98: 1102–1106CrossRefPubMedGoogle Scholar
  63. 63.
    Zamanian RT, Haddad F, Doyle RL, Weinacker AB (2007) Management strategies for patients with pulmonary hypertension in the intensive care unit. Crit Care Med 35: 2037–2050CrossRefPubMedGoogle Scholar
  64. 64.
    Breslow MJ, Miller CF, Parker SD, Walman AT, Traystman RJ (1987) Effect of vasopressors on organ blood flow during endotoxin shock in pigs. Am J Physiol 252:H291–300PubMedGoogle Scholar
  65. 65.
    Schwarz B, Hofstotter H, Salak N, et al (2001) Effects of norepinephrine and phenylephrine on intestinal oxygen supply and mucosal tissue oxygen tension. Intensive Care Med 27: 593–601CrossRefPubMedGoogle Scholar
  66. 66.
    Zhang H, De Jongh R, De Backer D, Cherkaoui S, Vray B, Vincent JL (2001) Effects of alpha 496 C. Ertmer, A. Morelli, and M. Westphal — and beta — adrenergic stimulation on hepatosplanchnic perfusion and oxygen extraction in endotoxic shock. Crit Care Med 29: 581–588CrossRefPubMedGoogle Scholar
  67. 67.
    Krejci V, Hiltebrand LB, Sigurdsson GH (2006) Effects of epinephrine, norepinephrine, and phenylephrine on microcirculatory blood flow in the gastrointestinal tract in sepsis. Crit Care Med 34: 1456–1463CrossRefPubMedGoogle Scholar
  68. 68.
    Pittner RA, Spitzer JA (1993) Shift from alpha-to beta-type adrenergic receptor-mediated responses in chronically endotoxemic rats. Am J Physiol 264:E650–654PubMedGoogle Scholar
  69. 69.
    Bellomo R, Wan L, May C (2008) Vasoactive drugs and acute kidney injury. Crit Care Med 36 (Suppl 4): S179–186CrossRefGoogle Scholar
  70. 70.
    Silfvast T, Saarnivaara L, Kinnunen A, et al (1985) Comparison of adrenaline and phenylephrine in out-of-hospital cardiopulmonary resuscitation. A double-blind study. Acta Anaesthesiol Scand 29: 610–613CrossRefPubMedGoogle Scholar
  71. 71.
    American Heart Association (2005) Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 112 (Suppl 24):IV1–203Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  • C. Ertmer
    • 1
  • A. Morelli
    • 2
  • M. Westphal
    • 1
  1. 1.Department of Anesthesiology and Intensive CareUniversity Hosptial of MünsterMünsterGermany
  2. 2.Department of Anesthesiology and Intensive CareUniversity of Rome “La Sapienza”RomeItaly

Personalised recommendations